Trading Update
Logotype for THG PLC

THG (THG) Trading Update summary

Event summary combining transcript, slides, and related documents.

Logotype for THG PLC

Trading Update summary

9 Jan, 2026

Nutrition division performance and outlook

  • Whey protein market volatility is expected to normalize with 9% new supply in 2024, mainly from the US, and further capacity in Europe in 2025.

  • Whey prices are assumed to remain high in H1 2024, with a 25% reduction expected in H2, potentially restoring profitability as prices ease.

  • Myprotein remains the UK's top sports nutrition brand, expanding licensing and retail partnerships with 14 new licensed products in H2 2024.

  • D2C model in India accelerated growth and new customer acquisition.

  • 2025 guidance for nutrition expects mid-single digit growth, supported by normalized pricing, FX improvements, and higher average selling prices.

Beauty division performance and strategy

  • Beauty retail saw 3.3% growth in Q4 2023 (ex-manufacturing), up from 2.5% in Q3, with strong performance from Lookfantastic and Cult Beauty.

  • The division underwent a major overhaul, focusing on profitable customers and pulling back from less profitable, distant markets, impacting some volume metrics.

  • Beauty margins have reached medium-term targets ahead of schedule, with ongoing focus on maintaining profitability while driving top-line growth.

  • Lookfantastic partnered with The White Company and doubled cyber period visits vs. nearest peer.

  • Expansion into physical retail with Lookfantastic stores is underway, aiming to enhance brand supply and customer experience.

Financial position and capital allocation

  • Group holds £400 million in cash and £150 million in unused revolving credit facility, with reduced CapEx and lease costs following the Ingenuity demerger.

  • Gross leverage materially reduced, with approximately £550m in year-end cash and available facilities.

  • Focus is on reducing gross leverage and interest costs, leveraging improved cash generation as nutrition margins recover.

  • Capital expenditure to reduce to ~£20m p.a., and cash lease costs to ~£22m p.a.

  • Future cash generation to support further deleveraging toward a neutral net cash/net debt position.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more